43 related articles for article (PubMed ID: 354771)
1. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization.
Rutanen EM; Lindgren J; Sipponen P; Stenman UP; Saksela E; Seppäla M
Cancer; 1978 Aug; 42(2):581-90. PubMed ID: 354771
[No Abstract] [Full Text] [Related]
2. Virus-augmented delayed hypersensitivity skin tests in gynecological malignancies.
Freedman RS; Bowen JM; Atkinson EN; Scott W; Wagner S
Cancer Immunol Immunother; 1984; 17(2):142-6. PubMed ID: 6088033
[TBL] [Abstract][Full Text] [Related]
3. Editorial: Harnessing tumor microenvironment for gynecologic cancer therapy.
Zhou L; Yi M
Front Immunol; 2024; 15():1407128. PubMed ID: 38650941
[No Abstract] [Full Text] [Related]
4. Use of carcinoembryonic antigen in follow-up of patients with ovarian cancer.
Koch M; McPherson TA; Starreveld AA
Can Med Assoc J; 1980 Nov; 123(9):848. PubMed ID: 20313507
[No Abstract] [Full Text] [Related]
5. Presence of carcinoembryonic antigen (CEA) in the normal and inflamed human parotid gland. An immunohistochemical study of 31 cases.
Caselitz J; Seifert G; Jaup T
J Cancer Res Clin Oncol; 1981; 100(2):205-11. PubMed ID: 7021564
[TBL] [Abstract][Full Text] [Related]
6. Morphology of the spleen in women who died of metastatic genital tract cancer.
Syrjänen KJ
Arch Gynecol; 1980; 230(1):33-40. PubMed ID: 6969063
[TBL] [Abstract][Full Text] [Related]
7. Cardiac failure, hepatic congestion and increased level of serum carcinoembryonic antigen.
Pönkä A; Forslund T
Postgrad Med J; 1984 Jan; 60(699):56-7. PubMed ID: 6694949
[TBL] [Abstract][Full Text] [Related]
8. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of carcinoembryonic antigen (CEA) in parotid gland carcinomas. Analysis of 52 cases.
Caselitz J; Jaup T; Seifert G
Virchows Arch A Pathol Anat Histol; 1981; 394(1-2):49-60. PubMed ID: 6278701
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.
Jalanko H; Kuusela P; Roberts P; Sipponen P; Haglund CA; Mäkelä O
J Clin Pathol; 1984 Feb; 37(2):218-22. PubMed ID: 6198342
[TBL] [Abstract][Full Text] [Related]
11. Oncofoetal antigens in cancer of the cervix and ovary.
Cauchi MN; Koh SH; Lim D; Hay DL
Br J Cancer; 1981 Sep; 44(3):403-9. PubMed ID: 6169360
[TBL] [Abstract][Full Text] [Related]
12. Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
Haglund C
Br J Cancer; 1986 Dec; 54(6):897-901. PubMed ID: 3467786
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.
Haglund C; Roberts PJ; Kuusela P; Scheinin TM; Mäkelä O; Jalanko H
Br J Cancer; 1986 Feb; 53(2):197-202. PubMed ID: 3456787
[TBL] [Abstract][Full Text] [Related]
14. Tumour-associated trypsin inhibitor (TATI) in ovarian cancer.
Halila H; Lehtovirta P; Stenman UH
Br J Cancer; 1988 Mar; 57(3):304-7. PubMed ID: 3162682
[TBL] [Abstract][Full Text] [Related]
15. Distribution of epithelial antigens in the human uterine cervix: a review.
Serra V; Ramirez A; Marzo MC; Valcuende F; Lara C; Castells A; Bonilla-Musoles F
Arch Gynecol Obstet; 1989; 246(2):61-84. PubMed ID: 2684044
[TBL] [Abstract][Full Text] [Related]
16. Lectin binding properties of cells from serous effusion and peritoneal washing specimens.
Shield PW
J Clin Pathol; 1989 Nov; 42(11):1178-83. PubMed ID: 2479665
[TBL] [Abstract][Full Text] [Related]
17. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
Kuusela P; Haglund C; Roberts PJ; Jalanko H
Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
[TBL] [Abstract][Full Text] [Related]
18. Production and characterisation of a monoclonal antibody (Cx-99) against cervical carcinoma.
Yuan CC; Tsai LC; Hsu SC; Ng HT; Tsai SJ; Chen HM; Hung MW; Ho CK; Ho DM; Gill TJ
Br J Cancer; 1992 Feb; 65(2):201-7. PubMed ID: 1739618
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen in endoscopic brush specimens from benign and malignant gastric lesions.
Lindgren J; Sipponen P; Seppälä K; Tarpila S; Nordling S; Wahlström T; Seppälä M
Br J Cancer; 1979 Dec; 40(6):848-55. PubMed ID: 393292
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary.
Heald J; Buckley CH; Fox H
J Clin Pathol; 1979 Sep; 32(9):918-26. PubMed ID: 229130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
